| Application no. and date | 10013180.4 (espacenet) (Federated) (European Patent Register), 20000127 | | Patent/reg. no. and date | DK/EP 2314321, 20140604 | | Publication date | 20110427 | | Priority no. and date | NZ 33392899, 19990127, NZ 50019099, 19991007 | | EP pub. no. and date |
EP 2314321 20110427 | | Effective date | | | Applicant/owner | Coda Therapeutics, Inc., 12520 High Bluff Drive
Suite 350
San Diego
CA 92130, US | | Applicant ref. no. | 02240-EP-DK | | Inventor | Becker, David Laurence, 19 Lapwing Way
Abbots Langley
Hertfordshire, WD5 0GG, GB,
Green, Colin Richard, 3/4 Crescent Road
Epsom
Auckland, NZ | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/70 (2006.01) , A61K 48/00 (2006.01) , A61P 17/02 (2006.01) , C12N 15/11 (2006.01) | | Title | Formuleringer, der omfatter antisense-nukleotider til connexiner | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
